Substituted 5-aryl-2,4-thiazolidinediones are potent agonists of PPAR, and
are therefore useful in the treatment, control or prevention of diabetes,
hyperglycemia, hyperlipidemia (including hypercholesterolemia and
hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis, and
other PPAR .alpha., .delta. and/or .gamma. mediated diseases, disorders
and conditions.